Infinity Pharmaceuticals Cash Beginning of Year Trend

Infinity Pharmaceuticals Inc -- USA Stock  

USD 1.83  0.01  0.55%

This module enables investors to look at Infinity Pharmaceuticals various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Cost of Revenue of 32.5 M, Gross Profit of 18.7 M or Interest Expense of 5.8 M, but also many exotic indicators such as Long Term Debt to Equity of 0.2339, PPandE Turnover of 9.9897 or Receivables Turnover of 1 K. This module is a perfect complement to use when analyzing Infinity Pharmaceuticals Valuation or Volatility. It can also complement various Infinity Pharmaceuticals Technical models. Please also check analysis of Infinity Pharmaceuticals Correlation with competitors.
Showing smoothed Cash Beginning of Year of Infinity Pharmaceuticals Inc with missing and latest data points interpolated.
Cash Beginning of Year  10 Years Trend  
Increasing
Slightly volatile
 Cash Beginning of Year 
      Timeline 

Infinity Pharmaceuticals Cash Beginning of Year Over Time

2015-12-31  307,405,000 
2016-12-31  307,405,000 
2017-12-31  197,641,579 

Other Fundumenentals

 

Regression Statistics

Arithmetic Mean  108,770,253
Geometric Mean  62,847,720
Coefficient Of Variation  101.73
Mean Deviation  92,185,428
Median  74,147,479
Standard Deviation  110,653,289
Range  291,117,771
R Value  0.7
R Squared  0.5
Significance  0.01046
Slope  21,633,833

Currently Trending

GOOG   
 NMS 
Purchased few shares of
2 hours ago ago
Traded for 1040.48
F   
 NYQ 
Purchased over 200 shares of
2 hours ago ago
Traded for 12.6
TWTR   
 NYQ 
Purchased over 100 shares of
2 hours ago ago
Traded for 21.65